Vertex Pharmaceuticals Incorporated Stock Performance
as on September 19, 2025 at 12:42 am IST
Day's Low
Day's High
$384.87$390.66
0.55%
Downside
0.95%
Upside
52 Week's Low
52 Week's High
$362.5$519.886.33%
Downside
34.34%
Upside
Vertex Pharmaceuticals Incorporated share price movements today
- Previous Close
- $387.15
- Open
- $389.69
- Volume
- 1.1M
- Day's Low - High
- $384.87 - $390.66
- 52 Week Low - High
- $362.5 - $519.88
Vertex Pharmaceuticals Incorporated Historical Returns
- 1 Month Return
- -0.7 %
- 3 Month Return
- -13.66 %
- 1 Year Return
- -18.35 %
- 3 Year Return
- + 33.63 %
- 5 Year Return
- + 45.88 %
Vertex Pharmaceuticals Incorporated Stock Fundamentals & Key Indicators
Check Vertex Pharmaceuticals Incorporated market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$99.3B
EPS (TTM)
18.0327
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.41%
PE Ratio (TTM)
27.56
Industry PE ratio
16.65525641025641
P/B Ratio
27.5552
PEG Ratio
0.5801
EBITDA
4.8B
Revenue (TTM)
11.4B
Profit Margin
31.86%
Return On Equity TTM
22.77%
Vertex Pharmaceuticals Incorporated Stock Valuation
Track how Vertex Pharmaceuticals Incorporated P/E has moved over time to understand its valuation trends.
Vertex Pharmaceuticals Incorporated in the last 5 years
Lowest (14.94x)
December 31, 2021
Industry (16.66x)
September 18, 2025
Today (27.56x)
September 18, 2025
Highest (29.01x)
September 30, 2020
Today’s Price to Earnings Ratio: 27.56x
Vertex Pharmaceuticals Incorporated vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Vertex Pharmaceuticals Incorporated with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
| BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
| NA | $38.7B | NA | NA | -3.89% | |
| BUY | $60.9B | 5.45% | 14.49 | 31.37% |
Stock Returns calculator for Vertex Pharmaceuticals Incorporated Stock including INR - Dollar returns
The Vertex Pharmaceuticals Incorporated stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Vertex Pharmaceuticals Incorporated investment value today
Current value as on today
₹86,569
Returns
Returns from Vertex Pharmaceuticals Incorporated Stock
Dollar Returns*
₹4,953 (+4.95%)
Analyst Recommendation on Vertex Pharmaceuticals Incorporated Stock
Based on 38 analysts
68.42%
Buy
26.32%
Hold
5.26%
Sell
Based on 38 analysts, 68.42% of analysts recommend a 'BUY' rating for Vertex Pharmaceuticals Incorporated. Average target price of $479.64
Vertex Pharmaceuticals Incorporated Share Price Target
Get share price movements and forecasts by analysts on Vertex Pharmaceuticals Incorporated.
What analysts predicted
19.32%UPSIDE
Target Price
$479.64
Current Price
$386.99
Analyzed by
38 Analysts
Target
$479.64
Vertex Pharmaceuticals Incorporated target price $479.64, a slight upside of 19.32% compared to current price of $386.99. According to 38 analysts rating.
Vertex Pharmaceuticals Incorporated Stock's Interest Amongst Investors
Investment in Vertex Pharmaceuticals Incorporated Shares on INDmoney has dropped by -45.18% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Vertex Pharmaceuticals Incorporated Stock has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Vertex Pharmaceuticals Incorporated Quarterly Profit & Loss
All numbers in Millions USD
Vertex Pharmaceuticals Incorporated Annual Profit & Loss
All numbers in Millions USD
Vertex Pharmaceuticals Incorporated Quarterly Cash Flow
All numbers in Millions USD
Vertex Pharmaceuticals Incorporated Annual Cash Flow
All numbers in Millions USD
Vertex Pharmaceuticals Incorporated News & Key Events
Today's Timeline - 05 August
Tue, 10:20 AM
-TD Cowen analyst maintains Buy rating on Vertex, citing strong financials despite VX-993 trial failure.
Tue, 02:29 PM
-Vertex announces VX-993 failed Phase 2 trial, leading to a 14% stock drop despite strong Q2 results.
Tue, 04:04 PM
-Vertex shares slide 14% after announcing it won't proceed with advanced testing of its experimental painkiller.
Insights on Vertex Pharmaceuticals Incorporated
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Vertex Pharmaceuticals Incorporated has shown a positive trend in its net profit over the last two quarters. The net profit increased from $646.3 million to $1.03 billion, reflecting an average increase of 37.4% per quarter.
- POSITIVE IMPACT
Revenue Rich
Vertex Pharmaceuticals Incorporated has shown a positive revenue trend over the last two quarters. In the most recent quarter, the revenue increased to $2.96 billion, up from $2.77 billion in the previous quarter. This represents an average increase of 6.6% in revenue each quarter.
NO EFFECTAgainst Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 86.8%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 77.9%
NEGATIVE IMPACTPrice Dip
In the last 3 months, VRTX stock has moved down by -13.7%
About Vertex Pharmaceuticals Incorporated
| Organisation | Vertex Pharmaceuticals Incorporated |
| Headquarters | 50 Northern Avenue, Boston, MA, United States, 02210 |
| Industry | Health Technology |
| CEO | Dr. Reshma Kewalramani FASN, M.D. |
| E-voting on shares | Click here to vote |
Key Management of Vertex Pharmaceuticals Incorporated
Name | Title |
|---|---|
Dr. Jeffrey Marc Leiden M.D., Ph.D. | Executive Chairman |
Mr. Charles F. Wagner Jr. | Executive VP, COO & CFO |
Dr. David M. Altshuler M.D., Ph.D. | Executive VP & Chief Scientific Officer |
Dr. Ourania Tatsis Ph.D. | Executive VP and Chief Regulatory & Quality Officer |
Ms. Nina Devlin | Senior VP & Chief Communications Officer |
Dr. Reshma Kewalramani FASN, M.D. | CEO, President & Director |
Ms. Kristen C. Ambrose CPA | Senior VP & Chief Accounting Officer |
Ms. Susie Lisa C.F.A. | Senior Vice President of Investor Relations |
Mr. Jonathan Biller J.D. | Executive VP & Chief Legal Officer |
Ms. Stephanie Franklin | Senior VP & Chief Human Resources Officer |
FAQs
What is Vertex Pharmaceuticals Incorporated share price today?
Vertex Pharmaceuticals Incorporated share price today is $386.99 as on . Vertex Pharmaceuticals Incorporated share today touched a day high of $390.66 and a low of $384.87.
What is the 52 week high and 52 week low for Vertex Pharmaceuticals Incorporated share?
Vertex Pharmaceuticals Incorporated share touched a 52 week high of $519.88 on and a 52 week low of $362.5 on . Vertex Pharmaceuticals Incorporated stock price today i.e. is trending at $386.99,which is 25.56% down from its 52 week high and 6.76% up from its 52 week low.
What is Vertex Pharmaceuticals Incorporated's market capitalisation today?
Vertex Pharmaceuticals Incorporated market capitalisation is $0.10T as on .
How to invest in Vertex Pharmaceuticals Incorporated Stock (VRTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Vertex Pharmaceuticals Incorporated on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vertex Pharmaceuticals Incorporated Shares that will get you 0.0039 shares as per Vertex Pharmaceuticals Incorporated share price of $386.99 per share as on September 19, 2025 at 12:42 am IST.
What is the minimum amount required to buy Vertex Pharmaceuticals Incorporated Stock (VRTX) from India?
Indian investors can start investing in Vertex Pharmaceuticals Incorporated (VRTX) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Vertex Pharmaceuticals Incorporated stock (as per the Rupee-Dollar exchange rate as on ).
Based on Vertex Pharmaceuticals Incorporated share’s latest price of $386.99 as on September 19, 2025 at 12:42 am IST, you will get 0.0258 shares of Vertex Pharmaceuticals Incorporated. Learn more about
fractional shares .
What are the returns that Vertex Pharmaceuticals Incorporated has given to Indian investors in the last 5 years?
Vertex Pharmaceuticals Incorporated stock has given 45.88% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?